# Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

> **NCT02305979** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 61 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** Loratadine

## Key facts

- **NCT ID:** NCT02305979
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305979, "Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02305979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*